Cardiology Encounters for Underrepresented Racial and Ethnic Groups with Human Immunodeficiency Virus and Borderline Cardiovascular Disease Risk

被引:4
|
作者
Bloomfield, Gerald S. [1 ,2 ]
Hill, C. Larry [2 ]
Chiswell, Karen [2 ]
Cooper, Linda [3 ]
Gray, Shamea [1 ]
Longenecker, Chris T. [4 ,5 ]
Louzao, Darcy [2 ]
Marsolo, Keith [2 ,6 ]
Meissner, Eric G. [3 ]
Morse, Caryn G. [7 ]
Muiruri, Charles [6 ]
Thomas, Kevin L. [1 ,2 ]
Velazquez, Eric J. [8 ]
Vicini, Joseph [9 ]
Pettit, April C. [9 ]
Sanders, Gretchen [2 ]
Okeke, Nwora Lance [1 ,6 ]
机构
[1] Duke Univ, Dept Med, Sch Med, Durham, NC 27701 USA
[2] Duke Univ, Duke Clin Res Inst, Sch Med, 300 W Morgan St, Durham, NC 27701 USA
[3] Med Univ South Carolina, Dept Med, Charleston, SC USA
[4] Univ Washington, Div Cardiol, Seattle, WA USA
[5] Univ Washington, Dept Global Hlth, Seattle, WA USA
[6] Duke Univ, Dept Populat Hlth Sci, Sch Med, Durham, NC USA
[7] Wake Forest Univ Hlth Sci, Winston Salem, NC USA
[8] Yale Univ, Sect Cardiovasc Med, New Haven, CT USA
[9] Vanderbilt Univ, Dept Med, Nashville, TN USA
关键词
HIV; Cardiovascular disease; Underrepresented racial and ethnic groups; Referral and consultation; Risk factors; PRIMARY-CARE; PRIMARY PREVENTION; INSURANCE STATUS; HIV; RACE; DISPARITIES; POPULATION; MANAGEMENT; PHYSICIANS; MORTALITY;
D O I
10.1007/s40615-023-01627-0
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundUnderrepresented racial and ethnic groups (UREGs) with HIV have a higher risk of cardiovascular disease (CVD) compared with the general population. Referral to a cardiovascular specialist improves CVD risk factor management in high-risk individuals. However, patient and provider factors impacting the likelihood of UREGs with HIV to have an encounter with a cardiologist are unknown.MethodsWe evaluated a cohort of UREGs with HIV and borderline CVD risk (10-year risk >= 5% by the pooled cohort equations or >= 7.5% by Framingham risk score). Participants received HIV-related care from 2014-2020 at four academic medical centers in the United States (U.S.). Adjusted Cox proportional hazards regression was used to estimate the association of patient and provider characteristics with time to first ambulatory cardiology encounter.ResultsA total of 2,039 people with HIV (PWH) and borderline CVD risk were identified. The median age was 45 years (IQR: 36-50); 52% were female; and 94% were Black. Of these participants, 283 (14%) had an ambulatory visit with a cardiologist (17% of women vs. 11% of men, p < .001). In fully adjusted models, older age, higher body mass index (BMI), atrial fibrillation, multimorbidity, urban residence, and no recent insurance were associated with a greater likelihood of an encounter with a cardiologist.ConclusionIn UREGs with HIV and borderline CVD risk, the strongest determinants of a cardiology encounter were diagnosed CVD, insurance type, and urban residence. Future research is needed to determine the extent to which these encounters impact CVD care practices and outcomes in this population.
引用
收藏
页码:1509 / 1519
页数:11
相关论文
共 50 条
  • [1] Cardiology Encounters for Underrepresented Racial and Ethnic Groups with Human Immunodeficiency Virus and Borderline Cardiovascular Disease Risk
    Gerald S. Bloomfield
    C. Larry Hill
    Karen Chiswell
    Linda Cooper
    Shamea Gray
    Chris T. Longenecker
    Darcy Louzao
    Keith Marsolo
    Eric G. Meissner
    Caryn G. Morse
    Charles Muiruri
    Kevin L. Thomas
    Eric J. Velazquez
    Joseph Vicini
    April C. Pettit
    Gretchen Sanders
    Nwora Lance Okeke
    Journal of Racial and Ethnic Health Disparities, 2024, 11 : 1509 - 1519
  • [2] Rates of Cardiovascular Disease and CKD Progression in Young Adults with CKD across Racial and Ethnic Groups
    Kula, Alexander J.
    Prince, David K.
    Limonte, Christine P.
    Young, Bessie A.
    Bansal, Nisha
    KIDNEY360, 2022, 3 (05): : 834 - 842
  • [3] Human Immunodeficiency Virus as a Risk Factor for Cardiovascular Disease
    Lembas, Agnieszka
    Zaleski, Andrzej
    Peller, Michal
    Mikula, Tomasz
    Wiercinska-Drapalo, Alicja
    CARDIOVASCULAR TOXICOLOGY, 2024, 24 (01) : 1 - 14
  • [4] Racial and Ethnic Disparities in Cardiovascular Disease Risk Among Patients with Chronic Kidney Disease
    Demilade A. Adedinsewo
    Ivan E. Porter
    Richard O. White
    LaTonya J. Hickson
    Current Cardiovascular Risk Reports, 2022, 16 : 145 - 157
  • [5] Racial and Ethnic Disparities in Cardiovascular Disease Risk Among Patients with Chronic Kidney Disease
    Adedinsewo, Demilade A.
    Porter, Ivan E., II
    White, Richard O.
    Hickson, LaTonya J.
    CURRENT CARDIOVASCULAR RISK REPORTS, 2022, 16 (11) : 145 - 157
  • [6] Cardiovascular disease in human immunodeficiency virus
    Cheruvu, S.
    Holloway, C. J.
    INTERNAL MEDICINE JOURNAL, 2014, 44 (04) : 315 - 324
  • [7] Human Immunodeficiency Virus as a Risk Factor for Cardiovascular Disease
    Agnieszka Lembas
    Andrzej Załęski
    Michał Peller
    Tomasz Mikuła
    Alicja Wiercińska-Drapało
    Cardiovascular Toxicology, 2024, 24 : 1 - 14
  • [8] Cardiovascular disease in patients with chronic human immunodeficiency virus infection
    Escarcega, Ricardo O.
    Franco, Joseph J.
    Mani, Bhalaghuru Chokkalingam
    Vyas, Apurva
    Tedaldi, Ellen M.
    Bove, Alfred A.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 175 (01) : 1 - 7
  • [9] Cardiovascular Disease Risk Factor Control in People With and Without Human Immunodeficiency Virus
    Silverberg, Michael J.
    Levine, Tory M.
    Lea, Alexandra N.
    Williams, Andrew E.
    Alexeeff, Stacey E.
    Bryant, Kendall
    Cavassini, Matthias
    Flamm, Jason A.
    Hare, C. Bradley
    Ingle, Suzanne M.
    Justice, Amy C.
    Lam, Jennifer O.
    Sterling, Stacy A.
    Horberg, Michael A.
    Satre, Derek D.
    CLINICAL INFECTIOUS DISEASES, 2024, 78 (05) : 1264 - 1271
  • [10] IS THE RISK OF CARDIOVASCULAR DISEASE DUE TO HUMAN IMMUNODEFICIENCY VIRUS INFECTION OR ITS THERAPY?
    Pravallika, S.
    Dhivya, K.
    Deekshitha, P.
    Kesini, M.
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (02): : 799 - 804